banner add

F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

October 30, 2025 0
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.

from NYT > Health https://ift.tt/blQEIcz
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

C.D.C. Ignored Request From States to Validate a New Measles Test

The agency replied two months later, saying it had “competing priorities,” officials from a coalition of Western states said. from NYT ...

Theme images by PLAINVIEW. Powered by Blogger.